Table of contents

Extended reports

• A novel gene variation of TNFα associated with ankylosing spondylitis: a reconfirmed study

  (1 May, 2007)

  Xiaoquan Zhu, Yawen Wang, Liang Sun, Yuguo Song, Fei Sun, Lei Tang, Zhenghao Huo, Jianxin Li, Ze Yang
• Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis (19 April, 2007)

  Sunita Suri, Sarah E Gill, Sally Massena de Camin, Daniel F McWilliams, Deborah Wilson, David A Walsh
• Gelatinase expression and proteolytic activity in giant-cell arteritis (14 May, 2007)

  Marta Segarra, Ana García-Martínez, Montse Sánchez, José Hernández-Rodríguez, Ester Lozano, Josep M Grau, Maria C Cid
• The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis

  (6 February, 2007)

  B Z Alizadeh, O T Njajou, J M W Hazes, A Hofman, P E Slagboom, H A P Pols, C M van Duijn
• Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) (22 May, 2007) Free

  S M M Verstappen, J W G Jacobs, M J van der Veen, A H M Heurkens, Y Schenk, E J ter Borg, A A M Blaauw, J W J Bijlsma, on the behalf of the Utrecht Rheumatoid Arthritis Cohort study group
• Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis (1 May, 2007)

  Marja-Kaisa Koivula, Markku Heliövaara, Jarmo Ramberg, Paul Knekt, Harri Rissanen, Timo Palosuo, Juha Risteli
• Predicting poor functional outcome in community-dwelling older adults with knee pain: prognostic value of generic indicators (24 April, 2007)

  Christian D Mallen, George Peat, Elaine Thomas, Rosie Lacey, Peter Croft
• Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis (14 May, 2007)

  Jenny Augustsson, Staffan Eksborg, Sofia Ernestam, Eleanor Gullström, Ronald van Vollenhoven
• Selective endothelin_A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

  (1 May, 2007)

  Reda E Girgis, Adaani E Frost, Nicholas S Hill, Evelyn M Horn, David Langleben, Vallerie V McLaughlin, Ronald J Oudiz, Ivan M Robbins, James R Seibold, Shelley Shapiro, Victor F Tapson, Robyn J Barst
• The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice (10 April, 2007)

  W Kievit, J Fransen, A J M Oerlemans, H H Kuper, M A F J van der Laar, D J R A M de Rooij, C M A De Gendt, K H Ronday, T L Jansen, P C M van Oijen, H L M Brus, E M Adang, P L C M van Riel
• Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis (24 April, 2007)

  Henning Christian Brandt, Inge Spiller, In-Ho Song, Janis L Vahldiek, Martin Rudwaleit, Joachim Sieper
• Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment (1 May, 2007)

  Peter M ten Klooster, Martine M Veehof, Erik Taal, Piet L C M van Riel, Mart A F J van de Laar
• QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries (5 April, 2007)

  Tuulikki Sokka, Hannu Kautiainen, Sergio Toloza, Heidi Mäkinen, Suzan M M Verstappen, Merete Lund Hetland, Antonio Naranjo, Eva Baecklund, Gertraud Herborn, Rolf Rau, Massimiliano Cazzato, Laure Gossec, Vlado Skakic, Feride Gogus, Stanislaw Sierakowski, Barry Bresnihan, Peter Taylor, Catherine McClinton, Theodore Pincus, for the QUEST-RA Group
• Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis (9 May, 2007)

  N A Shadick, J E Heller, M E Weinblatt, N E Maher, J Cui, G Ginsburg, J Coblyn, R Anderson, D H Solomon, R Roubenoff, A Parker
• Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis (1 May, 2007)

  Calin Popa, Frank H J van den Hoogen, Timothy R D J Radstake, Mihai G Netea, Agnes E Eijsbouts, Martin den Heijer, Jos W M van der Meer, Piet L C M van Riel, Anton F H Stalenhoef, Pilar Barrera
• Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis (9 May, 2007) Free

  Glenn Haugeberg, Michael J Green, Philip G Conaghan, Mark Quinn, Richard Wakefield, Susanna M Proudman, Sheena Stewart, Elizabeth Hensor, Paul Emery
• Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment (9 May, 2007)

  Marion A J van Rossum, Renée M van Soesbergen, Maarten Boers, Aeilko H Zwinderman, Theo J W Fiselier, Marcel J A M Franssen, Rebecca ten Cate, Lisette W A van Suijlekom-Smit, Nico M Wulffraat, Wietse Kuis, Wilma H J van Luijk, Johanna C M Oostveen, Ben A C Dijkmans, on behalf of the Dutch Juvenile Idiopathic Arthritis Study group
• Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor α-neutralising treatments in rheumatoid arthritis (24 April, 2007)

  Timothy R D J Radstake, Jaap Fransen, Erik J M Toonen, Marieke J H Coenen, Agnes E Eijsbouts, Rachelle Donn, Frank H J van den Hoogen, Piet L C M van Riel